by Jim Lane (Biofuels Digest) As birds migrate in the spring, we see many transitions going on in the bioeconomy right now too. From a new CEO for Transform Materials (a company that uses microwave plasma technology to convert natural gas into acetylene and hydrogen), some departures from Stora Enso and the Roundtable on Sustainable Biomaterials, new board members at AgBiome, Protera, Biotalysis, and Eagle Genomics, to an impressive 10 new bioeconomy additions at Lee Enterprises Consulting, check out all the latest moves from your friends and colleagues in the bio sectors. READ MORE
Tags
Share this article
Share this article
The successful British scale-up has attracted senior figures in international business development, pharmaceutical commercial strategy and nutrition innovation in San Diego, Cambridge Massachusetts, and New York to help shape the next phase of its worldwide growth
CAMBRIDGE, United Kingdom, May 11, 2021 /PRNewswire/ Eagle Genomics, a pioneer in applying network science to biology, has announced the appointment of three prestigious US-based advisory board members to its global panel, to help shape the next phase of its growth internationally. The move comes as the world s biggest brands in food, personal care and agriculture biotechnology (AgBio) look to play their part in addressing real-world challenges with innovative, sustainable, next-generation products that work symbiotically with the microbiome.
Serum Institute to invest 240 million pounds in UK, expand vaccine business
Serum Institute to invest 240 million pounds in UK, expand vaccine business
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership.
advertisement
UPDATED: May 4, 2021 09:19 IST
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business. (Reuters)
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, bio
(0)
The British success story continues apace as the biggest names in food, cosmetics, personal care & agritech globally look to confirm the positive biological impact of next-generation products, and play their part in solving real-world challenges capitalising on the worldwide microbiome megatrend
CAMBRIDGE, England, May 4, 2021 /PRNewswire/ Eagle Genomics, a British pioneer in applying network science to biology, has announced the opening of a formal new operation in India - within the innovation hub of Laxmi Cyber City in Hyderabad - as the bio revolution continues to transform the global economy.
Eagle Genomics has been hitting the headlines over the last year, with its ground-breaking approach to networking microbiome science - with its
Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investments
SECTIONS
Last Updated: May 04, 2021, 09:28 AM IST
Share
Synopsis
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
Agencies
It was also revealed that the Serum Institute of India (SII) has started phase one trials in the UK of a nasal vaccine against coronavirus.
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment pla